Todd Brinton
Chief Scientific Officer , Edwards Lifesciences
Todd J. Brinton, M.D., has been corporate vice president, advanced technology, and chief
scientific officer, since 2019. Dr. Brinton has significant experience as a champion of
cardiovascular innovation and has a strong patient focus as a tenured practicing clinical
cardiologist. He has deep ties to the medical technology community as a founder, board
member and advisor to several start-up companies, including his role as physician founder,
board member, and chief medical officer of ShockWave Medical, Inc. Dr. Brinton began his
career as an engineer in the medical technology industry, ultimately becoming a director of
clinical research and development, prior to entering medical school. Before joining Edwards, he
was a clinical professor of medicine (cardiology) and adjunct professor of bioengineering at the
Stanford University School of Medicine. He was an attending interventional cardiologist at both
the Stanford University Medical Center and the Palo Alto VA Medical Center. Dr. Brinton also
served as the fellowship director at the Stanford Byers Center for Biodesign from 2006 to 2019,
where he mentored and directed numerous teams on the development of new technologies. In
addition, he served as the co-director for both the graduate and executive education programs
at the center during a similar time period. He is extremely active in the American Heart
Association serving as the Chair of the 2022 Bay Area Research Roundtable and the 2022
Orange County Heart & Stroke Ball. In addition, he currently serves on the AHA national
research committee and strategic outcomes subcommittee. He has served on the advisory
board for the Edwards Lifesciences Foundation Cardiovascular Innovation and Research Center
at UC Irvine since 2020. Dr. Brinton received his bachelor’s degree from the University of
California, San Diego in biomedical engineering, and his medical degree from the Chicago
Medical School at Rosalind Franklin University. He completed his internship, residency, and
fellowships in cardiology and interventional cardiology at Stanford.
